Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile...
122 insider purchases on record · latest filing 2023-06-06.
Insiders have also filed 1,847 sale transactions at CSTL.